ARID1A and neoplasm: This data suggested that while ATR responses in HCT116 ARID1A−/− tumour cells to IR are impaired32, this was not the case in a variety of tumour cells exposed to cisplatin (Supplementary Fig. 1A,B) or other replication fork stalling lesions32.